Ouster (OUST) director sells shares under 10b5-1 plan and gets RSUs
Rhea-AI Filing Summary
Ouster director Ted L. Tewksbury III reported both an equity grant and a small share sale. On June 17, 2026, he acquired 4,725 shares of common stock at $0 as a grant tied to restricted stock units that vest quarterly through the earlier of June 17, 2027 or the 2027 annual meeting, subject to continued service. On June 22, 2026, he sold 1,695 shares of common stock at $47.00 per share in an open-market transaction under a pre-arranged Rule 10b5-1 plan that includes tax planning sales. Following these transactions, he directly holds 124,999 shares of Ouster common stock.
Positive
- None.
Negative
- None.
Insights
Routine RSU grant plus small pre-planned sale; net position remains large.
The filing shows a standard director compensation event and a modest liquidity move. Ted L. Tewksbury III received 4,725 shares as a grant at $0, representing restricted stock units that vest quarterly through the earlier of June 17, 2027 or the 2027 annual meeting.
He then sold 1,695 shares at $47.00 per share on June 22, 2026 in an open-market transaction executed under a pre-arranged Rule 10b5-1 plan, with footnotes noting tax planning purposes. This structure generally signals routine portfolio management rather than discretionary timing.
After these movements, his direct holdings stand at 124,999 shares of common stock, so the sale represents a small fraction of his position. With no derivative positions listed and vesting tied to continued service, subsequent company filings may provide additional context on future RSU vesting and any further plan-based sales.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,695 | $47.00 | $80K |
| Grant/Award | Common Stock | 4,725 | $0.00 | -- |
Footnotes (1)
- Consists of Ouster, Inc. (the "Company") restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in quarterly installments through the earlier of June 17, 2027 or the Company's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. The RSUs have no expiration date. The Reporting Person will settle all awards of common stock received, including vested RSUs, upon the earlier of a change in control or separation from service with the Company. Reflects shares sold pursuant to a Rule 10b5-1 plan dated August 12, 2025. Includes sales made for tax planning purposes.